Medical Care
Global Artificial Intelligence in Pathology Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 18, 25
- ID: 590649
- Pages: 148
- Figures: 160
- Views: 54
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Artificial Intelligence in Pathology market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
PathAI
Proscia
Aiforia
Deep Bio
Hologic
Dipath
iDeepwise
LBP
F.Q pathtech
CellaVision
AIRA Matrix
Syntropy
Indica Labs
DoMore Diagnostics
Mindpeak
Evidium
Segment by Type
Diagnosis Support
Predictive Modeling
Pattern Recognition
Image Analysis and Detection
Other
Segment by Application
Hospital
Diagnostic Centers
Laboratories & Research Institutes
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Artificial Intelligence in Pathology study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Artificial Intelligence in Pathology market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
PathAI
Proscia
Aiforia
Deep Bio
Hologic
Dipath
iDeepwise
LBP
F.Q pathtech
CellaVision
AIRA Matrix
Syntropy
Indica Labs
DoMore Diagnostics
Mindpeak
Evidium
Segment by Type
Diagnosis Support
Predictive Modeling
Pattern Recognition
Image Analysis and Detection
Other
Segment by Application
Hospital
Diagnostic Centers
Laboratories & Research Institutes
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Artificial Intelligence in Pathology study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Artificial Intelligence in Pathology: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Artificial Intelligence in Pathology Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Diagnosis Support
1.2.3 Predictive Modeling
1.2.4 Pattern Recognition
1.2.5 Image Analysis and Detection
1.2.6 Other
1.3 Market Segmentation by Application
1.3.1 Global Artificial Intelligence in Pathology Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Diagnostic Centers
1.3.4 Laboratories & Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Artificial Intelligence in Pathology Revenue Estimates and Forecasts 2020-2031
2.2 Global Artificial Intelligence in Pathology Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Artificial Intelligence in Pathology Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Artificial Intelligence in Pathology Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Diagnosis Support Market Size by Players
3.3.2 Predictive Modeling Market Size by Players
3.3.3 Pattern Recognition Market Size by Players
3.3.4 Image Analysis and Detection Market Size by Players
3.3.5 Other Market Size by Players
3.4 Global Artificial Intelligence in Pathology Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Artificial Intelligence in Pathology Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Artificial Intelligence in Pathology Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Artificial Intelligence in Pathology Market Size by Type (2020-2031)
6.4 North America Artificial Intelligence in Pathology Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Artificial Intelligence in Pathology Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Artificial Intelligence in Pathology Market Size by Type (2020-2031)
7.4 Europe Artificial Intelligence in Pathology Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Artificial Intelligence in Pathology Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Artificial Intelligence in Pathology Market Size by Type (2020-2031)
8.4 Asia-Pacific Artificial Intelligence in Pathology Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Artificial Intelligence in Pathology Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Artificial Intelligence in Pathology Market Size by Type (2020-2031)
9.4 Central and South America Artificial Intelligence in Pathology Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Artificial Intelligence in Pathology Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Artificial Intelligence in Pathology Market Size by Type (2020-2031)
10.4 Middle East and Africa Artificial Intelligence in Pathology Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Artificial Intelligence in Pathology Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 PathAI
11.1.1 PathAI Corporation Information
11.1.2 PathAI Business Overview
11.1.3 PathAI Artificial Intelligence in Pathology Product Features and Attributes
11.1.4 PathAI Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.1.5 PathAI Artificial Intelligence in Pathology Revenue by Product in 2024
11.1.6 PathAI Artificial Intelligence in Pathology Revenue by Application in 2024
11.1.7 PathAI Artificial Intelligence in Pathology Revenue by Geographic Area in 2024
11.1.8 PathAI Artificial Intelligence in Pathology SWOT Analysis
11.1.9 PathAI Recent Developments
11.2 Proscia
11.2.1 Proscia Corporation Information
11.2.2 Proscia Business Overview
11.2.3 Proscia Artificial Intelligence in Pathology Product Features and Attributes
11.2.4 Proscia Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.2.5 Proscia Artificial Intelligence in Pathology Revenue by Product in 2024
11.2.6 Proscia Artificial Intelligence in Pathology Revenue by Application in 2024
11.2.7 Proscia Artificial Intelligence in Pathology Revenue by Geographic Area in 2024
11.2.8 Proscia Artificial Intelligence in Pathology SWOT Analysis
11.2.9 Proscia Recent Developments
11.3 Aiforia
11.3.1 Aiforia Corporation Information
11.3.2 Aiforia Business Overview
11.3.3 Aiforia Artificial Intelligence in Pathology Product Features and Attributes
11.3.4 Aiforia Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.3.5 Aiforia Artificial Intelligence in Pathology Revenue by Product in 2024
11.3.6 Aiforia Artificial Intelligence in Pathology Revenue by Application in 2024
11.3.7 Aiforia Artificial Intelligence in Pathology Revenue by Geographic Area in 2024
11.3.8 Aiforia Artificial Intelligence in Pathology SWOT Analysis
11.3.9 Aiforia Recent Developments
11.4 Deep Bio
11.4.1 Deep Bio Corporation Information
11.4.2 Deep Bio Business Overview
11.4.3 Deep Bio Artificial Intelligence in Pathology Product Features and Attributes
11.4.4 Deep Bio Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.4.5 Deep Bio Artificial Intelligence in Pathology Revenue by Product in 2024
11.4.6 Deep Bio Artificial Intelligence in Pathology Revenue by Application in 2024
11.4.7 Deep Bio Artificial Intelligence in Pathology Revenue by Geographic Area in 2024
11.4.8 Deep Bio Artificial Intelligence in Pathology SWOT Analysis
11.4.9 Deep Bio Recent Developments
11.5 Hologic
11.5.1 Hologic Corporation Information
11.5.2 Hologic Business Overview
11.5.3 Hologic Artificial Intelligence in Pathology Product Features and Attributes
11.5.4 Hologic Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.5.5 Hologic Artificial Intelligence in Pathology Revenue by Product in 2024
11.5.6 Hologic Artificial Intelligence in Pathology Revenue by Application in 2024
11.5.7 Hologic Artificial Intelligence in Pathology Revenue by Geographic Area in 2024
11.5.8 Hologic Artificial Intelligence in Pathology SWOT Analysis
11.5.9 Hologic Recent Developments
11.6 Dipath
11.6.1 Dipath Corporation Information
11.6.2 Dipath Business Overview
11.6.3 Dipath Artificial Intelligence in Pathology Product Features and Attributes
11.6.4 Dipath Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.6.5 Dipath Recent Developments
11.7 iDeepwise
11.7.1 iDeepwise Corporation Information
11.7.2 iDeepwise Business Overview
11.7.3 iDeepwise Artificial Intelligence in Pathology Product Features and Attributes
11.7.4 iDeepwise Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.7.5 iDeepwise Recent Developments
11.8 LBP
11.8.1 LBP Corporation Information
11.8.2 LBP Business Overview
11.8.3 LBP Artificial Intelligence in Pathology Product Features and Attributes
11.8.4 LBP Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.8.5 LBP Recent Developments
11.9 F.Q pathtech
11.9.1 F.Q pathtech Corporation Information
11.9.2 F.Q pathtech Business Overview
11.9.3 F.Q pathtech Artificial Intelligence in Pathology Product Features and Attributes
11.9.4 F.Q pathtech Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.9.5 F.Q pathtech Recent Developments
11.10 CellaVision
11.10.1 CellaVision Corporation Information
11.10.2 CellaVision Business Overview
11.10.3 CellaVision Artificial Intelligence in Pathology Product Features and Attributes
11.10.4 CellaVision Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 AIRA Matrix
11.11.1 AIRA Matrix Corporation Information
11.11.2 AIRA Matrix Business Overview
11.11.3 AIRA Matrix Artificial Intelligence in Pathology Product Features and Attributes
11.11.4 AIRA Matrix Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.11.5 AIRA Matrix Recent Developments
11.12 Syntropy
11.12.1 Syntropy Corporation Information
11.12.2 Syntropy Business Overview
11.12.3 Syntropy Artificial Intelligence in Pathology Product Features and Attributes
11.12.4 Syntropy Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.12.5 Syntropy Recent Developments
11.13 Indica Labs
11.13.1 Indica Labs Corporation Information
11.13.2 Indica Labs Business Overview
11.13.3 Indica Labs Artificial Intelligence in Pathology Product Features and Attributes
11.13.4 Indica Labs Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.13.5 Indica Labs Recent Developments
11.14 DoMore Diagnostics
11.14.1 DoMore Diagnostics Corporation Information
11.14.2 DoMore Diagnostics Business Overview
11.14.3 DoMore Diagnostics Artificial Intelligence in Pathology Product Features and Attributes
11.14.4 DoMore Diagnostics Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.14.5 DoMore Diagnostics Recent Developments
11.15 Mindpeak
11.15.1 Mindpeak Corporation Information
11.15.2 Mindpeak Business Overview
11.15.3 Mindpeak Artificial Intelligence in Pathology Product Features and Attributes
11.15.4 Mindpeak Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.15.5 Mindpeak Recent Developments
11.16 Evidium
11.16.1 Evidium Corporation Information
11.16.2 Evidium Business Overview
11.16.3 Evidium Artificial Intelligence in Pathology Product Features and Attributes
11.16.4 Evidium Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.16.5 Evidium Recent Developments
12 Artificial Intelligence in PathologyIndustry Chain Analysis
12.1 Artificial Intelligence in Pathology Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Artificial Intelligence in Pathology Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Artificial Intelligence in Pathology Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Artificial Intelligence in Pathology: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Artificial Intelligence in Pathology Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Diagnosis Support
1.2.3 Predictive Modeling
1.2.4 Pattern Recognition
1.2.5 Image Analysis and Detection
1.2.6 Other
1.3 Market Segmentation by Application
1.3.1 Global Artificial Intelligence in Pathology Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Diagnostic Centers
1.3.4 Laboratories & Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Artificial Intelligence in Pathology Revenue Estimates and Forecasts 2020-2031
2.2 Global Artificial Intelligence in Pathology Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Artificial Intelligence in Pathology Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Artificial Intelligence in Pathology Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Diagnosis Support Market Size by Players
3.3.2 Predictive Modeling Market Size by Players
3.3.3 Pattern Recognition Market Size by Players
3.3.4 Image Analysis and Detection Market Size by Players
3.3.5 Other Market Size by Players
3.4 Global Artificial Intelligence in Pathology Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Artificial Intelligence in Pathology Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Artificial Intelligence in Pathology Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Artificial Intelligence in Pathology Market Size by Type (2020-2031)
6.4 North America Artificial Intelligence in Pathology Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Artificial Intelligence in Pathology Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Artificial Intelligence in Pathology Market Size by Type (2020-2031)
7.4 Europe Artificial Intelligence in Pathology Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Artificial Intelligence in Pathology Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Artificial Intelligence in Pathology Market Size by Type (2020-2031)
8.4 Asia-Pacific Artificial Intelligence in Pathology Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Artificial Intelligence in Pathology Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Artificial Intelligence in Pathology Market Size by Type (2020-2031)
9.4 Central and South America Artificial Intelligence in Pathology Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Artificial Intelligence in Pathology Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Artificial Intelligence in Pathology Market Size by Type (2020-2031)
10.4 Middle East and Africa Artificial Intelligence in Pathology Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Artificial Intelligence in Pathology Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 PathAI
11.1.1 PathAI Corporation Information
11.1.2 PathAI Business Overview
11.1.3 PathAI Artificial Intelligence in Pathology Product Features and Attributes
11.1.4 PathAI Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.1.5 PathAI Artificial Intelligence in Pathology Revenue by Product in 2024
11.1.6 PathAI Artificial Intelligence in Pathology Revenue by Application in 2024
11.1.7 PathAI Artificial Intelligence in Pathology Revenue by Geographic Area in 2024
11.1.8 PathAI Artificial Intelligence in Pathology SWOT Analysis
11.1.9 PathAI Recent Developments
11.2 Proscia
11.2.1 Proscia Corporation Information
11.2.2 Proscia Business Overview
11.2.3 Proscia Artificial Intelligence in Pathology Product Features and Attributes
11.2.4 Proscia Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.2.5 Proscia Artificial Intelligence in Pathology Revenue by Product in 2024
11.2.6 Proscia Artificial Intelligence in Pathology Revenue by Application in 2024
11.2.7 Proscia Artificial Intelligence in Pathology Revenue by Geographic Area in 2024
11.2.8 Proscia Artificial Intelligence in Pathology SWOT Analysis
11.2.9 Proscia Recent Developments
11.3 Aiforia
11.3.1 Aiforia Corporation Information
11.3.2 Aiforia Business Overview
11.3.3 Aiforia Artificial Intelligence in Pathology Product Features and Attributes
11.3.4 Aiforia Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.3.5 Aiforia Artificial Intelligence in Pathology Revenue by Product in 2024
11.3.6 Aiforia Artificial Intelligence in Pathology Revenue by Application in 2024
11.3.7 Aiforia Artificial Intelligence in Pathology Revenue by Geographic Area in 2024
11.3.8 Aiforia Artificial Intelligence in Pathology SWOT Analysis
11.3.9 Aiforia Recent Developments
11.4 Deep Bio
11.4.1 Deep Bio Corporation Information
11.4.2 Deep Bio Business Overview
11.4.3 Deep Bio Artificial Intelligence in Pathology Product Features and Attributes
11.4.4 Deep Bio Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.4.5 Deep Bio Artificial Intelligence in Pathology Revenue by Product in 2024
11.4.6 Deep Bio Artificial Intelligence in Pathology Revenue by Application in 2024
11.4.7 Deep Bio Artificial Intelligence in Pathology Revenue by Geographic Area in 2024
11.4.8 Deep Bio Artificial Intelligence in Pathology SWOT Analysis
11.4.9 Deep Bio Recent Developments
11.5 Hologic
11.5.1 Hologic Corporation Information
11.5.2 Hologic Business Overview
11.5.3 Hologic Artificial Intelligence in Pathology Product Features and Attributes
11.5.4 Hologic Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.5.5 Hologic Artificial Intelligence in Pathology Revenue by Product in 2024
11.5.6 Hologic Artificial Intelligence in Pathology Revenue by Application in 2024
11.5.7 Hologic Artificial Intelligence in Pathology Revenue by Geographic Area in 2024
11.5.8 Hologic Artificial Intelligence in Pathology SWOT Analysis
11.5.9 Hologic Recent Developments
11.6 Dipath
11.6.1 Dipath Corporation Information
11.6.2 Dipath Business Overview
11.6.3 Dipath Artificial Intelligence in Pathology Product Features and Attributes
11.6.4 Dipath Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.6.5 Dipath Recent Developments
11.7 iDeepwise
11.7.1 iDeepwise Corporation Information
11.7.2 iDeepwise Business Overview
11.7.3 iDeepwise Artificial Intelligence in Pathology Product Features and Attributes
11.7.4 iDeepwise Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.7.5 iDeepwise Recent Developments
11.8 LBP
11.8.1 LBP Corporation Information
11.8.2 LBP Business Overview
11.8.3 LBP Artificial Intelligence in Pathology Product Features and Attributes
11.8.4 LBP Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.8.5 LBP Recent Developments
11.9 F.Q pathtech
11.9.1 F.Q pathtech Corporation Information
11.9.2 F.Q pathtech Business Overview
11.9.3 F.Q pathtech Artificial Intelligence in Pathology Product Features and Attributes
11.9.4 F.Q pathtech Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.9.5 F.Q pathtech Recent Developments
11.10 CellaVision
11.10.1 CellaVision Corporation Information
11.10.2 CellaVision Business Overview
11.10.3 CellaVision Artificial Intelligence in Pathology Product Features and Attributes
11.10.4 CellaVision Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 AIRA Matrix
11.11.1 AIRA Matrix Corporation Information
11.11.2 AIRA Matrix Business Overview
11.11.3 AIRA Matrix Artificial Intelligence in Pathology Product Features and Attributes
11.11.4 AIRA Matrix Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.11.5 AIRA Matrix Recent Developments
11.12 Syntropy
11.12.1 Syntropy Corporation Information
11.12.2 Syntropy Business Overview
11.12.3 Syntropy Artificial Intelligence in Pathology Product Features and Attributes
11.12.4 Syntropy Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.12.5 Syntropy Recent Developments
11.13 Indica Labs
11.13.1 Indica Labs Corporation Information
11.13.2 Indica Labs Business Overview
11.13.3 Indica Labs Artificial Intelligence in Pathology Product Features and Attributes
11.13.4 Indica Labs Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.13.5 Indica Labs Recent Developments
11.14 DoMore Diagnostics
11.14.1 DoMore Diagnostics Corporation Information
11.14.2 DoMore Diagnostics Business Overview
11.14.3 DoMore Diagnostics Artificial Intelligence in Pathology Product Features and Attributes
11.14.4 DoMore Diagnostics Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.14.5 DoMore Diagnostics Recent Developments
11.15 Mindpeak
11.15.1 Mindpeak Corporation Information
11.15.2 Mindpeak Business Overview
11.15.3 Mindpeak Artificial Intelligence in Pathology Product Features and Attributes
11.15.4 Mindpeak Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.15.5 Mindpeak Recent Developments
11.16 Evidium
11.16.1 Evidium Corporation Information
11.16.2 Evidium Business Overview
11.16.3 Evidium Artificial Intelligence in Pathology Product Features and Attributes
11.16.4 Evidium Artificial Intelligence in Pathology Revenue and Gross Margin (2020-2025)
11.16.5 Evidium Recent Developments
12 Artificial Intelligence in PathologyIndustry Chain Analysis
12.1 Artificial Intelligence in Pathology Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Artificial Intelligence in Pathology Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Artificial Intelligence in Pathology Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Artificial Intelligence in Pathology Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Artificial Intelligence in Pathology Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Artificial Intelligence in Pathology Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Artificial Intelligence in Pathology Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Artificial Intelligence in Pathology Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Artificial Intelligence in Pathology Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Artificial Intelligence in Pathology Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Artificial Intelligence in Pathology by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence in Pathology as of 2024)
Table 11. Global Artificial Intelligence in Pathology Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Artificial Intelligence in Pathology Companies Headquarters
Table 13. Global Artificial Intelligence in Pathology Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Artificial Intelligence in Pathology Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Artificial Intelligence in Pathology Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Artificial Intelligence in Pathology Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Artificial Intelligence in Pathology Revenue by Application (2026-2031) & (US$ Million)
Table 21. Artificial Intelligence in Pathology High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Artificial Intelligence in Pathology Growth Accelerators and Market Barriers
Table 25. North America Artificial Intelligence in Pathology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Artificial Intelligence in Pathology Growth Accelerators and Market Barriers
Table 27. Europe Artificial Intelligence in Pathology Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Artificial Intelligence in Pathology Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Artificial Intelligence in Pathology Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Artificial Intelligence in Pathology Investment Opportunities and Key Challenges
Table 31. Central and South America Artificial Intelligence in Pathology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Artificial Intelligence in Pathology Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Artificial Intelligence in Pathology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. PathAI Corporation Information
Table 35. PathAI Description and Major Businesses
Table 36. PathAI Product Features and Attributes
Table 37. PathAI Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. PathAI Revenue Proportion by Product in 2024
Table 39. PathAI Revenue Proportion by Application in 2024
Table 40. PathAI Revenue Proportion by Geographic Area in 2024
Table 41. PathAI Artificial Intelligence in Pathology SWOT Analysis
Table 42. PathAI Recent Developments
Table 43. Proscia Corporation Information
Table 44. Proscia Description and Major Businesses
Table 45. Proscia Product Features and Attributes
Table 46. Proscia Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Proscia Revenue Proportion by Product in 2024
Table 48. Proscia Revenue Proportion by Application in 2024
Table 49. Proscia Revenue Proportion by Geographic Area in 2024
Table 50. Proscia Artificial Intelligence in Pathology SWOT Analysis
Table 51. Proscia Recent Developments
Table 52. Aiforia Corporation Information
Table 53. Aiforia Description and Major Businesses
Table 54. Aiforia Product Features and Attributes
Table 55. Aiforia Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Aiforia Revenue Proportion by Product in 2024
Table 57. Aiforia Revenue Proportion by Application in 2024
Table 58. Aiforia Revenue Proportion by Geographic Area in 2024
Table 59. Aiforia Artificial Intelligence in Pathology SWOT Analysis
Table 60. Aiforia Recent Developments
Table 61. Deep Bio Corporation Information
Table 62. Deep Bio Description and Major Businesses
Table 63. Deep Bio Product Features and Attributes
Table 64. Deep Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Deep Bio Revenue Proportion by Product in 2024
Table 66. Deep Bio Revenue Proportion by Application in 2024
Table 67. Deep Bio Revenue Proportion by Geographic Area in 2024
Table 68. Deep Bio Artificial Intelligence in Pathology SWOT Analysis
Table 69. Deep Bio Recent Developments
Table 70. Hologic Corporation Information
Table 71. Hologic Description and Major Businesses
Table 72. Hologic Product Features and Attributes
Table 73. Hologic Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Hologic Revenue Proportion by Product in 2024
Table 75. Hologic Revenue Proportion by Application in 2024
Table 76. Hologic Revenue Proportion by Geographic Area in 2024
Table 77. Hologic Artificial Intelligence in Pathology SWOT Analysis
Table 78. Hologic Recent Developments
Table 79. Dipath Corporation Information
Table 80. Dipath Description and Major Businesses
Table 81. Dipath Product Features and Attributes
Table 82. Dipath Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Dipath Recent Developments
Table 84. iDeepwise Corporation Information
Table 85. iDeepwise Description and Major Businesses
Table 86. iDeepwise Product Features and Attributes
Table 87. iDeepwise Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. iDeepwise Recent Developments
Table 89. LBP Corporation Information
Table 90. LBP Description and Major Businesses
Table 91. LBP Product Features and Attributes
Table 92. LBP Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. LBP Recent Developments
Table 94. F.Q pathtech Corporation Information
Table 95. F.Q pathtech Description and Major Businesses
Table 96. F.Q pathtech Product Features and Attributes
Table 97. F.Q pathtech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. F.Q pathtech Recent Developments
Table 99. CellaVision Corporation Information
Table 100. CellaVision Description and Major Businesses
Table 101. CellaVision Product Features and Attributes
Table 102. CellaVision Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. CellaVision Recent Developments
Table 104. AIRA Matrix Corporation Information
Table 105. AIRA Matrix Description and Major Businesses
Table 106. AIRA Matrix Product Features and Attributes
Table 107. AIRA Matrix Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. AIRA Matrix Recent Developments
Table 109. Syntropy Corporation Information
Table 110. Syntropy Description and Major Businesses
Table 111. Syntropy Product Features and Attributes
Table 112. Syntropy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Syntropy Recent Developments
Table 114. Indica Labs Corporation Information
Table 115. Indica Labs Description and Major Businesses
Table 116. Indica Labs Product Features and Attributes
Table 117. Indica Labs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Indica Labs Recent Developments
Table 119. DoMore Diagnostics Corporation Information
Table 120. DoMore Diagnostics Description and Major Businesses
Table 121. DoMore Diagnostics Product Features and Attributes
Table 122. DoMore Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. DoMore Diagnostics Recent Developments
Table 124. Mindpeak Corporation Information
Table 125. Mindpeak Description and Major Businesses
Table 126. Mindpeak Product Features and Attributes
Table 127. Mindpeak Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Mindpeak Recent Developments
Table 129. Evidium Corporation Information
Table 130. Evidium Description and Major Businesses
Table 131. Evidium Product Features and Attributes
Table 132. Evidium Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Evidium Recent Developments
Table 134. Raw Materials Key Suppliers
Table 135. Distributors List
Table 136. Market Trends and Market Evolution
Table 137. Market Drivers and Opportunities
Table 138. Market Challenges, Risks, and Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Artificial Intelligence in Pathology Product Picture
Figure 2. Global Artificial Intelligence in Pathology Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Diagnosis Support Product Picture
Figure 4. Predictive Modeling Product Picture
Figure 5. Pattern Recognition Product Picture
Figure 6. Image Analysis and Detection Product Picture
Figure 7. Other Product Picture
Figure 8. Global Artificial Intelligence in Pathology Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Hospital
Figure 10. Diagnostic Centers
Figure 11. Laboratories & Research Institutes
Figure 12. Artificial Intelligence in Pathology Report Years Considered
Figure 13. Global Artificial Intelligence in Pathology Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 15. Global Artificial Intelligence in Pathology Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Artificial Intelligence in Pathology Revenue Market Share by Region (2020-2031)
Figure 17. Global Artificial Intelligence in Pathology Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Diagnosis Support Revenue Market Share by Player in 2024
Figure 20. Predictive Modeling Revenue Market Share by Player in 2024
Figure 21. Pattern Recognition Revenue Market Share by Player in 2024
Figure 22. Image Analysis and Detection Revenue Market Share by Player in 2024
Figure 23. Other Revenue Market Share by Player in 2024
Figure 24. Global Artificial Intelligence in Pathology Revenue Market Share by Type (2020-2031)
Figure 25. Global Artificial Intelligence in Pathology Revenue Market Share by Application (2020-2031)
Figure 26. North America Artificial Intelligence in Pathology Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Players Artificial Intelligence in Pathology Revenue (US$ Million) in 2024
Figure 28. North America Artificial Intelligence in Pathology Revenue (US$ Million) by Type (2020 - 2031)
Figure 29. North America Artificial Intelligence in Pathology Revenue (US$ Million) by Application (2020-2031)
Figure 30. US Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 31. Canada Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 32. Mexico Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 33. Europe Artificial Intelligence in Pathology Revenue YoY (2020-2031) & (US$ Million)
Figure 34. Europe Top 5 Players Artificial Intelligence in Pathology Revenue (US$ Million) in 2024
Figure 35. Europe Artificial Intelligence in Pathology Revenue (US$ Million) by Type (2020-2031)
Figure 36. Europe Artificial Intelligence in Pathology Revenue (US$ Million) by Application (2020-2031)
Figure 37. Germany Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 38. France Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 39. U.K. Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 40. Italy Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 41. Russia Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Artificial Intelligence in Pathology Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Asia-Pacific Top 8 Players Artificial Intelligence in Pathology Revenue (US$ Million) in 2024
Figure 44. Asia-Pacific Artificial Intelligence in Pathology Revenue (US$ Million) by Type (2020-2031)
Figure 45. Asia-Pacific Artificial Intelligence in Pathology Revenue (US$ Million) by Application (2020-2031)
Figure 46. Indonesia Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 47. Japan Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 48. South Korea Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 49. Australia Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 50. India Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 51. Indonesia Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 52. Vietnam Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 53. Malaysia Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 54. Philippines Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 55. Singapore Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 56. Central and South America Artificial Intelligence in Pathology Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Central and South America Top 5 Players Artificial Intelligence in Pathology Revenue (US$ Million) in 2024
Figure 58. Central and South America Artificial Intelligence in Pathology Revenue (US$ Million) by Type (2020-2031)
Figure 59. Central and South America Artificial Intelligence in Pathology Revenue (US$ Million) by Application (2020-2031)
Figure 60. Brazil Artificial Intelligence in Pathology Revenue (2020-2025) & (US$ Million)
Figure 61. Argentina Artificial Intelligence in Pathology Revenue (2020-2025) & (US$ Million)
Figure 62. Middle East and Africa Artificial Intelligence in Pathology Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Middle East and Africa Top 5 Players Artificial Intelligence in Pathology Revenue (US$ Million) in 2024
Figure 64. South America Artificial Intelligence in Pathology Revenue (US$ Million) by Type (2020-2031)
Figure 65. Middle East and Africa Artificial Intelligence in Pathology Revenue (US$ Million) by Application (2020-2031)
Figure 66. GCC Countries Artificial Intelligence in Pathology Revenue (2020-2025) & (US$ Million)
Figure 67. Israel Artificial Intelligence in Pathology Revenue (2020-2025) & (US$ Million)
Figure 68. Egypt Artificial Intelligence in Pathology Revenue (2020-2025) & (US$ Million)
Figure 69. South Africa Artificial Intelligence in Pathology Revenue (2020-2025) & (US$ Million)
Figure 70. Artificial Intelligence in Pathology Industry Chain Mapping
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Table 1. Global Artificial Intelligence in Pathology Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Artificial Intelligence in Pathology Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Artificial Intelligence in Pathology Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Artificial Intelligence in Pathology Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Artificial Intelligence in Pathology Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Artificial Intelligence in Pathology Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Artificial Intelligence in Pathology Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Artificial Intelligence in Pathology by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence in Pathology as of 2024)
Table 11. Global Artificial Intelligence in Pathology Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Artificial Intelligence in Pathology Companies Headquarters
Table 13. Global Artificial Intelligence in Pathology Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Artificial Intelligence in Pathology Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Artificial Intelligence in Pathology Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Artificial Intelligence in Pathology Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Artificial Intelligence in Pathology Revenue by Application (2026-2031) & (US$ Million)
Table 21. Artificial Intelligence in Pathology High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Artificial Intelligence in Pathology Growth Accelerators and Market Barriers
Table 25. North America Artificial Intelligence in Pathology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Artificial Intelligence in Pathology Growth Accelerators and Market Barriers
Table 27. Europe Artificial Intelligence in Pathology Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Artificial Intelligence in Pathology Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Artificial Intelligence in Pathology Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Artificial Intelligence in Pathology Investment Opportunities and Key Challenges
Table 31. Central and South America Artificial Intelligence in Pathology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Artificial Intelligence in Pathology Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Artificial Intelligence in Pathology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. PathAI Corporation Information
Table 35. PathAI Description and Major Businesses
Table 36. PathAI Product Features and Attributes
Table 37. PathAI Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. PathAI Revenue Proportion by Product in 2024
Table 39. PathAI Revenue Proportion by Application in 2024
Table 40. PathAI Revenue Proportion by Geographic Area in 2024
Table 41. PathAI Artificial Intelligence in Pathology SWOT Analysis
Table 42. PathAI Recent Developments
Table 43. Proscia Corporation Information
Table 44. Proscia Description and Major Businesses
Table 45. Proscia Product Features and Attributes
Table 46. Proscia Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Proscia Revenue Proportion by Product in 2024
Table 48. Proscia Revenue Proportion by Application in 2024
Table 49. Proscia Revenue Proportion by Geographic Area in 2024
Table 50. Proscia Artificial Intelligence in Pathology SWOT Analysis
Table 51. Proscia Recent Developments
Table 52. Aiforia Corporation Information
Table 53. Aiforia Description and Major Businesses
Table 54. Aiforia Product Features and Attributes
Table 55. Aiforia Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Aiforia Revenue Proportion by Product in 2024
Table 57. Aiforia Revenue Proportion by Application in 2024
Table 58. Aiforia Revenue Proportion by Geographic Area in 2024
Table 59. Aiforia Artificial Intelligence in Pathology SWOT Analysis
Table 60. Aiforia Recent Developments
Table 61. Deep Bio Corporation Information
Table 62. Deep Bio Description and Major Businesses
Table 63. Deep Bio Product Features and Attributes
Table 64. Deep Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Deep Bio Revenue Proportion by Product in 2024
Table 66. Deep Bio Revenue Proportion by Application in 2024
Table 67. Deep Bio Revenue Proportion by Geographic Area in 2024
Table 68. Deep Bio Artificial Intelligence in Pathology SWOT Analysis
Table 69. Deep Bio Recent Developments
Table 70. Hologic Corporation Information
Table 71. Hologic Description and Major Businesses
Table 72. Hologic Product Features and Attributes
Table 73. Hologic Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Hologic Revenue Proportion by Product in 2024
Table 75. Hologic Revenue Proportion by Application in 2024
Table 76. Hologic Revenue Proportion by Geographic Area in 2024
Table 77. Hologic Artificial Intelligence in Pathology SWOT Analysis
Table 78. Hologic Recent Developments
Table 79. Dipath Corporation Information
Table 80. Dipath Description and Major Businesses
Table 81. Dipath Product Features and Attributes
Table 82. Dipath Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Dipath Recent Developments
Table 84. iDeepwise Corporation Information
Table 85. iDeepwise Description and Major Businesses
Table 86. iDeepwise Product Features and Attributes
Table 87. iDeepwise Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. iDeepwise Recent Developments
Table 89. LBP Corporation Information
Table 90. LBP Description and Major Businesses
Table 91. LBP Product Features and Attributes
Table 92. LBP Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. LBP Recent Developments
Table 94. F.Q pathtech Corporation Information
Table 95. F.Q pathtech Description and Major Businesses
Table 96. F.Q pathtech Product Features and Attributes
Table 97. F.Q pathtech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. F.Q pathtech Recent Developments
Table 99. CellaVision Corporation Information
Table 100. CellaVision Description and Major Businesses
Table 101. CellaVision Product Features and Attributes
Table 102. CellaVision Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. CellaVision Recent Developments
Table 104. AIRA Matrix Corporation Information
Table 105. AIRA Matrix Description and Major Businesses
Table 106. AIRA Matrix Product Features and Attributes
Table 107. AIRA Matrix Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. AIRA Matrix Recent Developments
Table 109. Syntropy Corporation Information
Table 110. Syntropy Description and Major Businesses
Table 111. Syntropy Product Features and Attributes
Table 112. Syntropy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Syntropy Recent Developments
Table 114. Indica Labs Corporation Information
Table 115. Indica Labs Description and Major Businesses
Table 116. Indica Labs Product Features and Attributes
Table 117. Indica Labs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Indica Labs Recent Developments
Table 119. DoMore Diagnostics Corporation Information
Table 120. DoMore Diagnostics Description and Major Businesses
Table 121. DoMore Diagnostics Product Features and Attributes
Table 122. DoMore Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. DoMore Diagnostics Recent Developments
Table 124. Mindpeak Corporation Information
Table 125. Mindpeak Description and Major Businesses
Table 126. Mindpeak Product Features and Attributes
Table 127. Mindpeak Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Mindpeak Recent Developments
Table 129. Evidium Corporation Information
Table 130. Evidium Description and Major Businesses
Table 131. Evidium Product Features and Attributes
Table 132. Evidium Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Evidium Recent Developments
Table 134. Raw Materials Key Suppliers
Table 135. Distributors List
Table 136. Market Trends and Market Evolution
Table 137. Market Drivers and Opportunities
Table 138. Market Challenges, Risks, and Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Artificial Intelligence in Pathology Product Picture
Figure 2. Global Artificial Intelligence in Pathology Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Diagnosis Support Product Picture
Figure 4. Predictive Modeling Product Picture
Figure 5. Pattern Recognition Product Picture
Figure 6. Image Analysis and Detection Product Picture
Figure 7. Other Product Picture
Figure 8. Global Artificial Intelligence in Pathology Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Hospital
Figure 10. Diagnostic Centers
Figure 11. Laboratories & Research Institutes
Figure 12. Artificial Intelligence in Pathology Report Years Considered
Figure 13. Global Artificial Intelligence in Pathology Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 15. Global Artificial Intelligence in Pathology Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Artificial Intelligence in Pathology Revenue Market Share by Region (2020-2031)
Figure 17. Global Artificial Intelligence in Pathology Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Diagnosis Support Revenue Market Share by Player in 2024
Figure 20. Predictive Modeling Revenue Market Share by Player in 2024
Figure 21. Pattern Recognition Revenue Market Share by Player in 2024
Figure 22. Image Analysis and Detection Revenue Market Share by Player in 2024
Figure 23. Other Revenue Market Share by Player in 2024
Figure 24. Global Artificial Intelligence in Pathology Revenue Market Share by Type (2020-2031)
Figure 25. Global Artificial Intelligence in Pathology Revenue Market Share by Application (2020-2031)
Figure 26. North America Artificial Intelligence in Pathology Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Players Artificial Intelligence in Pathology Revenue (US$ Million) in 2024
Figure 28. North America Artificial Intelligence in Pathology Revenue (US$ Million) by Type (2020 - 2031)
Figure 29. North America Artificial Intelligence in Pathology Revenue (US$ Million) by Application (2020-2031)
Figure 30. US Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 31. Canada Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 32. Mexico Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 33. Europe Artificial Intelligence in Pathology Revenue YoY (2020-2031) & (US$ Million)
Figure 34. Europe Top 5 Players Artificial Intelligence in Pathology Revenue (US$ Million) in 2024
Figure 35. Europe Artificial Intelligence in Pathology Revenue (US$ Million) by Type (2020-2031)
Figure 36. Europe Artificial Intelligence in Pathology Revenue (US$ Million) by Application (2020-2031)
Figure 37. Germany Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 38. France Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 39. U.K. Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 40. Italy Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 41. Russia Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Artificial Intelligence in Pathology Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Asia-Pacific Top 8 Players Artificial Intelligence in Pathology Revenue (US$ Million) in 2024
Figure 44. Asia-Pacific Artificial Intelligence in Pathology Revenue (US$ Million) by Type (2020-2031)
Figure 45. Asia-Pacific Artificial Intelligence in Pathology Revenue (US$ Million) by Application (2020-2031)
Figure 46. Indonesia Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 47. Japan Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 48. South Korea Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 49. Australia Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 50. India Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 51. Indonesia Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 52. Vietnam Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 53. Malaysia Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 54. Philippines Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 55. Singapore Artificial Intelligence in Pathology Revenue (2020-2031) & (US$ Million)
Figure 56. Central and South America Artificial Intelligence in Pathology Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Central and South America Top 5 Players Artificial Intelligence in Pathology Revenue (US$ Million) in 2024
Figure 58. Central and South America Artificial Intelligence in Pathology Revenue (US$ Million) by Type (2020-2031)
Figure 59. Central and South America Artificial Intelligence in Pathology Revenue (US$ Million) by Application (2020-2031)
Figure 60. Brazil Artificial Intelligence in Pathology Revenue (2020-2025) & (US$ Million)
Figure 61. Argentina Artificial Intelligence in Pathology Revenue (2020-2025) & (US$ Million)
Figure 62. Middle East and Africa Artificial Intelligence in Pathology Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Middle East and Africa Top 5 Players Artificial Intelligence in Pathology Revenue (US$ Million) in 2024
Figure 64. South America Artificial Intelligence in Pathology Revenue (US$ Million) by Type (2020-2031)
Figure 65. Middle East and Africa Artificial Intelligence in Pathology Revenue (US$ Million) by Application (2020-2031)
Figure 66. GCC Countries Artificial Intelligence in Pathology Revenue (2020-2025) & (US$ Million)
Figure 67. Israel Artificial Intelligence in Pathology Revenue (2020-2025) & (US$ Million)
Figure 68. Egypt Artificial Intelligence in Pathology Revenue (2020-2025) & (US$ Million)
Figure 69. South Africa Artificial Intelligence in Pathology Revenue (2020-2025) & (US$ Million)
Figure 70. Artificial Intelligence in Pathology Industry Chain Mapping
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232